Symbol:
Abr
Name:
ABR activator of RhoGEF and GTPase
RGD ID:
1306279
Description:
Predicted to enable GTPase activator activity and guanyl-nucleotide exchange factor activity. Predicted to be involved in several processes, including activation of GTPase activity; negative regulation of blood vessel remodeling; and negative regulation of cellular extravasation. Predicted to act upstream of or within several processes, including negative regulation of macrophage migration; regulation of vesicle-mediated transport; and response to lipopolysaccharide. Is active in glutamatergic synapse and postsynaptic density, intracellular component. Orthologous to human ABR (ABR activator of RhoGEF and GTPase); INTERACTS WITH 17alpha-ethynylestradiol; 2,3,7,8-tetrachlorodibenzodioxine; 3-chloropropane-1,2-diol.
Type:
protein-coding
RefSeq Status:
VALIDATED
Previously known as:
ABR, RhoGEF and GTPase activating protein; active BCR-related; active BCR-related gene; active breakpoint cluster region-related protein; breakpoint cluster region protein-like; LOC103693389; LOC287537; LOC687983; similar to Breakpoint cluster region protein
RGD Orthologs
Alliance Orthologs
More Info
more info ...
More Info
Latest Assembly:
GRCr8 - GRCr8 Assembly
Position:
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 10 61,760,743 - 61,959,526 (-) NCBI GRCr8 mRatBN7.2 10 61,262,516 - 61,461,331 (-) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 10 61,262,516 - 61,461,505 (-) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 10 65,908,046 - 66,051,300 (-) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 10 65,413,502 - 65,556,758 (-) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 10 60,883,717 - 61,026,573 (-) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 10 64,565,121 - 64,657,079 (-) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 10 64,567,268 - 64,657,089 (-) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 10 63,250,866 - 63,449,251 (+) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 10 67,617,776 - 67,760,961 (+) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 10 67,631,103 - 67,774,585 (+) NCBI Celera 10 60,277,504 - 60,420,210 (-) NCBI Celera Cytogenetic Map 10 q24 NCBI
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Only show annotations with direct experimental evidence (0 objects hidden)
Abr Rat (-)-epigallocatechin 3-gallate multiple interactions ISO ABR (Homo sapiens) 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ABR mRNA CTD PMID:22079256 Abr Rat (1->4)-beta-D-glucan multiple interactions ISO Abr (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of ABR mRNA CTD PMID:36331819 Abr Rat 1,2-dimethylhydrazine multiple interactions ISO Abr (Mus musculus) 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ABR mRNA CTD PMID:22206623 Abr Rat 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of ABR mRNA CTD PMID:29097150 Abr Rat 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO Abr (Mus musculus) 6480464 [2 more ... CTD PMID:25510870 Abr Rat 2,2',5,5'-tetrachlorobiphenyl multiple interactions ISO Abr (Mus musculus) 6480464 [2 more ... CTD PMID:25510870 Abr Rat 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Abr (Mus musculus) 6480464 Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to ABR gene] CTD PMID:20819909 Abr Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of ABR mRNA CTD PMID:32109520 Abr Rat 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Abr (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of ABR mRNA CTD PMID:21570461 Abr Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Abr (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in increased expression of ABR mRNA CTD PMID:20819909 Abr Rat 2-methylcholine affects expression ISO ABR (Homo sapiens) 6480464 beta-methylcholine affects the expression of ABR mRNA CTD PMID:21179406 Abr Rat 2-palmitoylglycerol increases expression ISO ABR (Homo sapiens) 6480464 2-palmitoylglycerol results in increased expression of ABR mRNA CTD PMID:37199045 Abr Rat 3,4-methylenedioxymethamphetamine decreases expression ISO Abr (Mus musculus) 6480464 N-Methyl-3 and 4-methylenedioxyamphetamine results in decreased expression of ABR mRNA CTD PMID:26251327 Abr Rat 3,4-methylenedioxymethamphetamine increases methylation ISO Abr (Mus musculus) 6480464 N-Methyl-3 and 4-methylenedioxyamphetamine results in increased methylation of ABR promoter CTD PMID:26251327 Abr Rat 3-chloropropane-1,2-diol decreases expression EXP 6480464 alpha-Chlorohydrin results in decreased expression of ABR mRNA CTD PMID:28522335 Abr Rat 4,4'-sulfonyldiphenol decreases methylation ISO ABR (Homo sapiens) 6480464 bisphenol S results in decreased methylation of ABR gene CTD PMID:31601247 Abr Rat 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of ABR mRNA CTD PMID:24780913 Abr Rat acetamide increases expression EXP 6480464 acetamide results in increased expression of ABR mRNA CTD PMID:31881176 Abr Rat aflatoxin B1 increases methylation ISO ABR (Homo sapiens) 6480464 Aflatoxin B1 results in increased methylation of ABR promoter CTD PMID:30157460 Abr Rat aflatoxin B1 affects methylation ISO ABR (Homo sapiens) 6480464 Aflatoxin B1 affects the methylation of ABR intron CTD PMID:30157460 Abr Rat Aflatoxin B2 alpha affects methylation ISO ABR (Homo sapiens) 6480464 aflatoxin B2 affects the methylation of ABR intron CTD PMID:30157460 Abr Rat Aflatoxin B2 alpha increases methylation ISO ABR (Homo sapiens) 6480464 aflatoxin B2 results in increased methylation of ABR promoter CTD PMID:30157460 Abr Rat amosite asbestos decreases methylation ISO ABR (Homo sapiens) 6480464 Asbestos and Amosite results in decreased methylation of ABR promoter CTD PMID:29626692 Abr Rat antirheumatic drug decreases expression ISO ABR (Homo sapiens) 6480464 Antirheumatic Agents results in decreased expression of ABR mRNA CTD PMID:24449571 Abr Rat arsane affects methylation ISO ABR (Homo sapiens) 6480464 Arsenic affects the methylation of ABR gene CTD PMID:25304211 Abr Rat arsane multiple interactions ISO ABR (Homo sapiens) 6480464 [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ABR mRNA CTD PMID:39836092 Abr Rat arsane decreases methylation ISO ABR (Homo sapiens) 6480464 Arsenic results in decreased methylation of ABR gene CTD PMID:31135185 Abr Rat arsenic atom affects methylation ISO ABR (Homo sapiens) 6480464 Arsenic affects the methylation of ABR gene CTD PMID:25304211 Abr Rat arsenic atom multiple interactions ISO ABR (Homo sapiens) 6480464 [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ABR mRNA CTD PMID:39836092 Abr Rat arsenic atom decreases methylation ISO ABR (Homo sapiens) 6480464 Arsenic results in decreased methylation of ABR gene CTD PMID:31135185 Abr Rat atrazine decreases expression ISO ABR (Homo sapiens) 6480464 Atrazine results in decreased expression of ABR mRNA CTD PMID:22378314 Abr Rat atrazine affects methylation EXP 6480464 Atrazine affects the methylation of ABR gene CTD PMID:35440735 Abr Rat benzo[a]pyrene decreases expression ISO ABR (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased expression of ABR mRNA CTD PMID:20064835 more ... Abr Rat benzo[a]pyrene affects methylation ISO ABR (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of ABR 5' UTR more ... CTD PMID:27901495 and PMID:30157460 Abr Rat benzo[a]pyrene increases methylation ISO Abr (Mus musculus) 6480464 Benzo(a)pyrene results in increased methylation of ABR intron CTD PMID:27901495 Abr Rat benzo[a]pyrene diol epoxide I decreases expression ISO ABR (Homo sapiens) 6480464 7 more ... CTD PMID:26238291 Abr Rat benzo[e]pyrene affects methylation ISO ABR (Homo sapiens) 6480464 benzo(e)pyrene affects the methylation of ABR intron CTD PMID:30157460 Abr Rat bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of ABR mRNA CTD PMID:25181051 Abr Rat bisphenol A decreases methylation ISO ABR (Homo sapiens) 6480464 bisphenol A results in decreased methylation of ABR gene CTD PMID:31601247 Abr Rat bisphenol A multiple interactions ISO ABR (Homo sapiens) 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of ABR gene CTD PMID:31601247 Abr Rat bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of ABR gene CTD PMID:28505145 Abr Rat bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of ABR mRNA CTD PMID:29097150 and PMID:34947998 Abr Rat bisphenol A increases expression ISO ABR (Homo sapiens) 6480464 bisphenol A results in increased expression of ABR mRNA CTD PMID:27685785 Abr Rat cadmium dichloride decreases expression ISO ABR (Homo sapiens) 6480464 Cadmium Chloride results in decreased expression of ABR mRNA CTD PMID:38568856 Abr Rat choline multiple interactions ISO Abr (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ABR mRNA CTD PMID:20938992 Abr Rat cisplatin affects response to substance ISO ABR (Homo sapiens) 6480464 ABR protein affects the susceptibility to Cisplatin CTD PMID:16217747 Abr Rat cisplatin decreases expression ISO ABR (Homo sapiens) 6480464 Cisplatin results in decreased expression of ABR mRNA CTD PMID:19561079 and PMID:27594783 Abr Rat cobalt dichloride decreases expression ISO ABR (Homo sapiens) 6480464 cobaltous chloride results in decreased expression of ABR mRNA CTD PMID:19320972 and PMID:19376846 Abr Rat copper(II) chloride increases expression ISO ABR (Homo sapiens) 6480464 cupric chloride results in increased expression of ABR mRNA CTD PMID:38568856 Abr Rat copper(II) sulfate increases expression ISO ABR (Homo sapiens) 6480464 Copper Sulfate results in increased expression of ABR mRNA CTD PMID:19549813 Abr Rat crocidolite asbestos decreases methylation ISO ABR (Homo sapiens) 6480464 Asbestos and Crocidolite results in decreased methylation of ABR promoter CTD PMID:29626692 Abr Rat cyclosporin A increases expression ISO ABR (Homo sapiens) 6480464 Cyclosporine results in increased expression of ABR mRNA CTD PMID:25562108 Abr Rat dibutyl phthalate decreases expression ISO Abr (Mus musculus) 6480464 Dibutyl Phthalate results in decreased expression of ABR mRNA CTD PMID:21266533 Abr Rat doxorubicin decreases expression ISO ABR (Homo sapiens) 6480464 Doxorubicin results in decreased expression of ABR mRNA CTD PMID:29803840 Abr Rat elemental selenium increases expression ISO ABR (Homo sapiens) 6480464 Selenium results in increased expression of ABR mRNA CTD PMID:19244175 Abr Rat ethanol multiple interactions ISO Abr (Mus musculus) 6480464 [Carbon Tetrachloride co-treated with Ethanol] results in increased expression of ABR mRNA CTD PMID:30517762 Abr Rat ethanol affects splicing ISO Abr (Mus musculus) 6480464 Ethanol affects the splicing of ABR mRNA CTD PMID:30319688 Abr Rat fenvalerate increases expression EXP 6480464 fenvalerate results in increased expression of ABR mRNA CTD PMID:30307764 Abr Rat folic acid multiple interactions ISO Abr (Mus musculus) 6480464 [1 more ... CTD PMID:20938992 and PMID:22206623 Abr Rat fulvestrant multiple interactions ISO ABR (Homo sapiens) 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of ABR gene CTD PMID:31601247 Abr Rat hydrogen peroxide affects expression ISO ABR (Homo sapiens) 6480464 Hydrogen Peroxide affects the expression of ABR mRNA CTD PMID:21179406 Abr Rat ivermectin decreases expression ISO ABR (Homo sapiens) 6480464 Ivermectin results in decreased expression of ABR protein CTD PMID:32959892 Abr Rat L-methionine multiple interactions ISO Abr (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ABR mRNA CTD PMID:20938992 Abr Rat lead(0) affects methylation ISO ABR (Homo sapiens) 6480464 Lead affects the methylation of ABR gene CTD PMID:31636367 Abr Rat menadione affects expression ISO ABR (Homo sapiens) 6480464 Vitamin K 3 affects the expression of ABR mRNA CTD PMID:20044591 Abr Rat methapyrilene affects methylation ISO ABR (Homo sapiens) 6480464 Methapyrilene affects the methylation of ABR intron CTD PMID:30157460 Abr Rat methoxychlor affects methylation EXP 6480464 Methoxychlor affects the methylation of ABR gene CTD PMID:35440735 Abr Rat methylmercury chloride affects expression EXP 6480464 methylmercuric chloride affects the expression of ABR mRNA CTD PMID:20864626 Abr Rat N-methyl-4-phenylpyridinium increases expression ISO ABR (Homo sapiens) 6480464 1-Methyl-4-phenylpyridinium results in increased expression of ABR mRNA CTD PMID:24810058 Abr Rat N-nitrosodiethylamine multiple interactions ISO Abr (Mus musculus) 6480464 [Piperonyl Butoxide co-treated with Diethylnitrosamine] affects the methylation of ABR gene CTD PMID:23968726 Abr Rat ozone multiple interactions ISO ABR (Homo sapiens) 6480464 [Air Pollutants results in increased abundance of Ozone] which affects the expression of ABR mRNA CTD PMID:35430440 Abr Rat PCB138 multiple interactions ISO Abr (Mus musculus) 6480464 [2 more ... CTD PMID:25510870 Abr Rat perfluorohexanesulfonic acid increases expression ISO Abr (Mus musculus) 6480464 perfluorohexanesulfonic acid results in increased expression of ABR mRNA CTD PMID:37995155 Abr Rat perfluorooctane-1-sulfonic acid multiple interactions ISO Abr (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of ABR mRNA CTD PMID:36331819 Abr Rat piperonyl butoxide multiple interactions ISO Abr (Mus musculus) 6480464 [Piperonyl Butoxide co-treated with Diethylnitrosamine] affects the methylation of ABR gene CTD PMID:23968726 Abr Rat potassium chromate multiple interactions ISO ABR (Homo sapiens) 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ABR mRNA CTD PMID:22079256 Abr Rat potassium chromate decreases expression ISO ABR (Homo sapiens) 6480464 potassium chromate(VI) results in decreased expression of ABR mRNA CTD PMID:22079256 Abr Rat selenium atom increases expression ISO ABR (Homo sapiens) 6480464 Selenium results in increased expression of ABR mRNA CTD PMID:19244175 Abr Rat serpentine asbestos decreases methylation ISO ABR (Homo sapiens) 6480464 Asbestos and Serpentine results in decreased methylation of ABR promoter CTD PMID:29626692 Abr Rat sodium arsenite increases expression ISO ABR (Homo sapiens) 6480464 sodium arsenite results in increased expression of ABR mRNA CTD PMID:17879257 more ... Abr Rat sodium arsenite multiple interactions ISO ABR (Homo sapiens) 6480464 [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ABR mRNA CTD PMID:39836092 Abr Rat sodium arsenite decreases expression ISO ABR (Homo sapiens) 6480464 sodium arsenite results in decreased expression of ABR mRNA CTD PMID:34032870 Abr Rat sunitinib increases expression ISO ABR (Homo sapiens) 6480464 Sunitinib results in increased expression of ABR mRNA CTD PMID:31533062 Abr Rat tert-butyl hydroperoxide increases expression ISO Abr (Mus musculus) 6480464 tert-Butylhydroperoxide results in increased expression of ABR mRNA CTD PMID:15003993 Abr Rat tetrachloromethane multiple interactions ISO Abr (Mus musculus) 6480464 [Carbon Tetrachloride co-treated with Ethanol] results in increased expression of ABR mRNA CTD PMID:30517762 Abr Rat thapsigargin increases expression EXP 6480464 Thapsigargin results in increased expression of ABR protein CTD PMID:35544339 Abr Rat titanium dioxide increases methylation ISO Abr (Mus musculus) 6480464 titanium dioxide results in increased methylation of ABR gene CTD PMID:35295148 Abr Rat titanium dioxide decreases methylation ISO Abr (Mus musculus) 6480464 titanium dioxide results in decreased methylation of ABR gene CTD PMID:35295148 Abr Rat toluene decreases expression ISO ABR (Homo sapiens) 6480464 Toluene results in decreased expression of ABR mRNA CTD PMID:26717081 Abr Rat toluene increases methylation ISO ABR (Homo sapiens) 6480464 Toluene results in increased methylation of ABR gene CTD PMID:26717081 Abr Rat triphenyl phosphate affects expression ISO ABR (Homo sapiens) 6480464 triphenyl phosphate affects the expression of ABR mRNA CTD PMID:37042841 Abr Rat triptonide increases expression ISO Abr (Mus musculus) 6480464 triptonide results in increased expression of ABR mRNA CTD PMID:33045310 Abr Rat tungsten decreases expression ISO Abr (Mus musculus) 6480464 Tungsten results in decreased expression of ABR mRNA CTD PMID:30912803 Abr Rat urethane decreases expression ISO ABR (Homo sapiens) 6480464 Urethane results in decreased expression of ABR mRNA CTD PMID:28818685 Abr Rat valproic acid increases expression ISO ABR (Homo sapiens) 6480464 Valproic Acid results in increased expression of ABR mRNA CTD PMID:23179753 Abr Rat valproic acid affects expression ISO ABR (Homo sapiens) 6480464 Valproic Acid affects the expression of ABR mRNA CTD PMID:25979313 Abr Rat valproic acid increases methylation ISO ABR (Homo sapiens) 6480464 Valproic Acid results in increased methylation of ABR gene CTD PMID:29154799
(-)-epigallocatechin 3-gallate (ISO) (1->4)-beta-D-glucan (ISO) 1,2-dimethylhydrazine (ISO) 17alpha-ethynylestradiol (EXP) 2,2',4,4',5,5'-hexachlorobiphenyl (ISO) 2,2',5,5'-tetrachlorobiphenyl (ISO) 2,3,7,8-tetrachlorodibenzodioxine (EXP,ISO) 2-methylcholine (ISO) 2-palmitoylglycerol (ISO) 3,4-methylenedioxymethamphetamine (ISO) 3-chloropropane-1,2-diol (EXP) 4,4'-sulfonyldiphenol (ISO) 6-propyl-2-thiouracil (EXP) acetamide (EXP) aflatoxin B1 (ISO) Aflatoxin B2 alpha (ISO) amosite asbestos (ISO) antirheumatic drug (ISO) arsane (ISO) arsenic atom (ISO) atrazine (EXP,ISO) benzo[a]pyrene (ISO) benzo[a]pyrene diol epoxide I (ISO) benzo[e]pyrene (ISO) bisphenol A (EXP,ISO) cadmium dichloride (ISO) choline (ISO) cisplatin (ISO) cobalt dichloride (ISO) copper(II) chloride (ISO) copper(II) sulfate (ISO) crocidolite asbestos (ISO) cyclosporin A (ISO) dibutyl phthalate (ISO) doxorubicin (ISO) elemental selenium (ISO) ethanol (ISO) fenvalerate (EXP) folic acid (ISO) fulvestrant (ISO) hydrogen peroxide (ISO) ivermectin (ISO) L-methionine (ISO) lead(0) (ISO) menadione (ISO) methapyrilene (ISO) methoxychlor (EXP) methylmercury chloride (EXP) N-methyl-4-phenylpyridinium (ISO) N-nitrosodiethylamine (ISO) ozone (ISO) PCB138 (ISO) perfluorohexanesulfonic acid (ISO) perfluorooctane-1-sulfonic acid (ISO) piperonyl butoxide (ISO) potassium chromate (ISO) selenium atom (ISO) serpentine asbestos (ISO) sodium arsenite (ISO) sunitinib (ISO) tert-butyl hydroperoxide (ISO) tetrachloromethane (ISO) thapsigargin (EXP) titanium dioxide (ISO) toluene (ISO) triphenyl phosphate (ISO) triptonide (ISO) tungsten (ISO) urethane (ISO) valproic acid (ISO)
Abr (Rattus norvegicus - Norway rat)
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 10 61,760,743 - 61,959,526 (-) NCBI GRCr8 mRatBN7.2 10 61,262,516 - 61,461,331 (-) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 10 61,262,516 - 61,461,505 (-) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 10 65,908,046 - 66,051,300 (-) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 10 65,413,502 - 65,556,758 (-) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 10 60,883,717 - 61,026,573 (-) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 10 64,565,121 - 64,657,079 (-) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 10 64,567,268 - 64,657,089 (-) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 10 63,250,866 - 63,449,251 (+) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 10 67,617,776 - 67,760,961 (+) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 10 67,631,103 - 67,774,585 (+) NCBI Celera 10 60,277,504 - 60,420,210 (-) NCBI Celera Cytogenetic Map 10 q24 NCBI
ABR (Homo sapiens - human)
Human Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCh38 17 1,003,519 - 1,229,722 (-) NCBI GRCh38 GRCh38 hg38 GRCh38 GRCh38.p14 Ensembl 17 1,003,519 - 1,229,738 (-) Ensembl GRCh38 hg38 GRCh38 GRCh37 17 906,759 - 1,133,016 (-) NCBI GRCh37 GRCh37 hg19 GRCh37 Build 36 17 853,509 - 1,029,881 (-) NCBI NCBI36 Build 36 hg18 NCBI36 Build 34 17 853,509 - 1,029,881 NCBI Celera 17 918,106 - 1,102,463 (-) NCBI Celera Cytogenetic Map 17 p13.3 NCBI HuRef 17 813,353 - 993,409 (-) NCBI HuRef CHM1_1 17 914,146 - 1,097,251 (-) NCBI CHM1_1 T2T-CHM13v2.0 17 890,209 - 1,120,740 (-) NCBI T2T-CHM13v2.0
Abr (Mus musculus - house mouse)
Mouse Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCm39 11 76,307,560 - 76,468,515 (-) NCBI GRCm39 GRCm39 mm39 GRCm39 Ensembl 11 76,307,560 - 76,514,384 (-) Ensembl GRCm39 Ensembl GRCm38 11 76,416,732 - 76,623,324 (-) NCBI GRCm38 GRCm38 mm10 GRCm38 GRCm38.p6 Ensembl 11 76,416,734 - 76,623,558 (-) Ensembl GRCm38 mm10 GRCm38 MGSCv37 11 76,230,236 - 76,391,229 (-) NCBI GRCm37 MGSCv37 mm9 NCBIm37 MGSCv36 11 76,232,929 - 76,393,922 (-) NCBI MGSCv36 mm8 Celera 11 83,928,368 - 84,081,980 (-) NCBI Celera Cytogenetic Map 11 B5 NCBI cM Map 11 45.92 NCBI
Abr (Chinchilla lanigera - long-tailed chinchilla)
Chinchilla Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChiLan1.0 Ensembl NW_004955481 2,503,315 - 2,654,244 (-) Ensembl ChiLan1.0 ChiLan1.0 NW_004955481 2,503,309 - 2,710,667 (-) NCBI ChiLan1.0 ChiLan1.0
ABR (Pan paniscus - bonobo/pygmy chimpanzee)
Bonobo Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl NHGRI_mPanPan1-v2 19 8,556,006 - 8,755,510 (-) NCBI NHGRI_mPanPan1-v2 NHGRI_mPanPan1 17 10,527,138 - 10,731,505 (-) NCBI NHGRI_mPanPan1 Mhudiblu_PPA_v0 17 972,009 - 1,174,953 (-) NCBI Mhudiblu_PPA_v0 Mhudiblu_PPA_v0 panPan3 PanPan1.1 17 893,413 - 1,116,064 (-) NCBI panpan1.1 PanPan1.1 panPan2 PanPan1.1 Ensembl 17 895,013 - 1,069,973 (-) Ensembl panpan1.1 panPan2
ABR (Canis lupus familiaris - dog)
Dog Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl CanFam3.1 9 44,634,117 - 44,821,454 (+) NCBI CanFam3.1 CanFam3.1 canFam3 CanFam3.1 CanFam3.1 Ensembl 9 44,681,411 - 44,819,249 (+) Ensembl CanFam3.1 canFam3 CanFam3.1 Dog10K_Boxer_Tasha 9 43,785,466 - 43,972,043 (+) NCBI Dog10K_Boxer_Tasha ROS_Cfam_1.0 9 45,451,750 - 45,638,302 (+) NCBI ROS_Cfam_1.0 ROS_Cfam_1.0 Ensembl 9 45,451,864 - 45,638,282 (+) Ensembl ROS_Cfam_1.0 Ensembl UMICH_Zoey_3.1 9 44,278,129 - 44,417,777 (+) NCBI UMICH_Zoey_3.1 UNSW_CanFamBas_1.0 9 44,517,664 - 44,703,775 (+) NCBI UNSW_CanFamBas_1.0 UU_Cfam_GSD_1.0 9 44,604,307 - 44,790,569 (+) NCBI UU_Cfam_GSD_1.0
Abr (Ictidomys tridecemlineatus - thirteen-lined ground squirrel)
Squirrel Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl HiC_Itri_2 NW_024405602 43,750,170 - 43,941,125 (+) NCBI HiC_Itri_2 SpeTri2.0 Ensembl NW_004936538 6,674,907 - 6,816,674 (+) Ensembl SpeTri2.0 SpeTri2.0 Ensembl SpeTri2.0 NW_004936538 6,674,595 - 6,819,511 (+) NCBI SpeTri2.0 SpeTri2.0 SpeTri2.0
ABR (Sus scrofa - pig)
Pig Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl Sscrofa11.1 Ensembl 12 46,709,880 - 46,895,808 (+) Ensembl Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa11.1 12 46,709,840 - 46,895,819 (+) NCBI Sscrofa11.1 Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa10.2 12 48,950,856 - 49,028,680 (-) NCBI Sscrofa10.2 Sscrofa10.2 susScr3
ABR (Chlorocebus sabaeus - green monkey)
Abr (Heterocephalus glaber - naked mole-rat)
.
Predicted Target Of
Count of predictions: 372 Count of miRNA genes: 198 Interacting mature miRNAs: 264 Transcripts: ENSRNOT00000032861 Prediction methods: Miranda, Rnahybrid, Targetscan Result types: miRGate_prediction
61441 Btemp1 Thermal response to stress QTL 1 4 body temperature trait (VT:0005535) core body temperature (CMO:0001036) 10 35392457 63642539 Rat 1549846 Scl47 Serum cholesterol level QTL 47 3.6 blood cholesterol amount (VT:0000180) serum total cholesterol level (CMO:0000363) 10 50574707 95574707 Rat 152025229 Scl83 Serum cholesterol level QTL 83 4.33 blood cholesterol amount (VT:0000180) 10 35710580 68663659 Rat 1578779 Tcas10 Tongue tumor susceptibility QTL 10 3.12 tongue integrity trait (VT:0010553) number of squamous cell tumors of the tongue with diameter greater than 3 mm (CMO:0001950) 10 31297439 76297439 Rat 152025227 Bw195 Body weight QTL 195 5.73 body mass (VT:0001259) 10 46989699 68663659 Rat 1298069 Bp168 Blood pressure QTL 168 5.5 blood pressure trait (VT:0000183) systolic blood pressure (CMO:0000004) 10 26521957 98003205 Rat 2293669 Bmd33 Bone mineral density QTL 33 4.5 0.0001 femur strength trait (VT:0010010) femoral neck polar moment of inertia (CMO:0001670) 10 49444551 81709989 Rat 152025224 Bw193 Body weight QTL 193 6.47 body mass (VT:0001259) 10 51663405 75085664 Rat 631552 Vetf2 Vascular elastic tissue fragility QTL 2 4.5 0.0002 aorta elastic tissue integrity trait (VT:0010556) artery internal elastic lamina non-tumorous lesion count (CMO:0001913) 10 41142633 86142633 Rat 631554 Bp133 Blood pressure QTL 133 0.005 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 10 743364 63851208 Rat 631557 Bp136 Blood pressure QTL 136 0.003 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 10 30632053 75632053 Rat 61325 Aia5 Adjuvant induced arthritis QTL 5 0.01 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 10 23444813 104060283 Rat 1298078 Stresp5 Stress response QTL 5 2.99 0.00025 blood corticosterone amount (VT:0005345) plasma corticosterone level (CMO:0001173) 10 42045676 104670812 Rat 2293679 Bmd30 Bone mineral density QTL 30 3.5 0.0001 femur mineral mass (VT:0010011) total volumetric bone mineral density (CMO:0001728) 10 49444551 81709989 Rat 1549831 Bss6 Bone structure and strength QTL 6 4 lumbar vertebra strength trait (VT:0010574) vertebra ultimate force (CMO:0001678) 10 57576521 102576521 Rat 2298544 Neuinf9 Neuroinflammation QTL 9 4.6 nervous system integrity trait (VT:0010566) spinal cord complement component 1, q subcomponent, B chain mRNA level (CMO:0002126) 10 5801990 62146030 Rat 70164 Bw21 Body weight QTL 21 4.36 0.00005 body mass (VT:0001259) body weight (CMO:0000012) 10 53797494 98952626 Rat 61463 Bp12 Blood pressure QTL 12 6.3 0.0001 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 10 41333258 86333258 Rat 8694173 Bw149 Body weight QTL 149 4.38 0.001 body mass (VT:0001259) body weight gain (CMO:0000420) 10 44441699 89441699 Rat 2300218 Hpcl2 Hepatic cholesterol level QTL 2 liver cholesterol amount (VT:0010498) liver cholesterol level (CMO:0001597) 10 45029650 95600334 Rat 1554317 Bmd4 Bone mineral density QTL 4 9.4 0.0001 lumbar vertebra mineral mass (VT:0010511) volumetric bone mineral density (CMO:0001553) 10 19816042 99406971 Rat 70171 Cari1 Carrageenan-induced inflammation QTL 1 4.9 0.0005 hypodermis integrity trait (VT:0010550) inflammatory exudate volume (CMO:0001429) 10 53797385 107211142 Rat 1598852 Anxrr19 Anxiety related response QTL 19 5.07 body movement coordination trait (VT:0005424) number of rearing movements in an experimental apparatus (CMO:0001752) 10 18167841 63167841 Rat 1581497 Esta1 Estrogen-induced thymic atrophy QTL 1 thymus mass (VT:0004954) thymus wet weight (CMO:0000855) 10 21329805 61345413 Rat 724527 Bp148 Blood pressure QTL 148 0.0001 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 10 28453136 73453136 Rat 1358897 Stresp6 Stress response QTL 6 4.17 0.022 blood norepinephrine amount (VT:0005663) plasma norepinephrine level (CMO:0001010) 10 35392267 64155584 Rat 1331762 Rf40 Renal function QTL 40 3.873 kidney blood vessel physiology trait (VT:0100012) absolute change in renal vascular resistance (CMO:0001900) 10 29299504 64155584 Rat 2300171 Bmd58 Bone mineral density QTL 58 4.9 0.0001 lumbar vertebra mineral mass (VT:0010511) volumetric bone mineral density (CMO:0001553) 10 26944628 71944628 Rat 61354 Pia10 Pristane induced arthritis QTL 10 0.01 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 10 23444813 104060283 Rat 2301967 Cm73 Cardiac mass QTL 73 4.55 heart left ventricle mass (VT:0007031) heart left ventricle weight to body weight ratio (CMO:0000530) 10 14487011 89062041 Rat 2303118 Mamtr7 Mammary tumor resistance QTL 7 0.003 mammary gland integrity trait (VT:0010552) mammary tumor growth rate (CMO:0000344) 10 9658275 104670812 Rat 70188 BpQTLcluster1 Blood pressure QTL cluster 1 4.864 arterial blood pressure trait (VT:2000000) pulse pressure (CMO:0000292) 1 42323132 87323132 Rat 9589030 Epfw9 Epididymal fat weight QTL 9 19.24 0.001 epididymal fat pad mass (VT:0010421) epididymal fat pad weight to body weight ratio (CMO:0000658) 10 44441699 89441699 Rat 10402859 Bp381 Blood pressure QTL 381 0.002 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 10 27606468 72606468 Rat 2316949 Gluco60 Glucose level QTL 60 3.7 blood glucose amount (VT:0000188) blood glucose level (CMO:0000046) 10 14487011 107057807 Rat 2293652 Bmd22 Bone mineral density QTL 22 4.9 0.0001 femur mineral mass (VT:0010011) total volumetric bone mineral density (CMO:0001728) 10 49444551 81709989 Rat 70198 BpQTLcluster9 Blood pressure QTL cluster 9 2.94 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 10 42323132 87323132 Rat 2306970 Anxrr22 Anxiety related response QTL 22 5.95 fear/anxiety-related behavior trait (VT:1000241) number of periods of voluntary immobility (CMO:0001045) 10 61345276 98211570 Rat 1359017 Hrtrt21 Heart rate QTL 21 2.4 heart pumping trait (VT:2000009) heart rate (CMO:0000002) 10 51772940 96772940 Rat 2306787 Ean3 Experimental allergic neuritis QTL 3 3.1 nervous system integrity trait (VT:0010566) body weight loss (CMO:0001399) 10 53797385 66979128 Rat 2312672 Insul15 Insulin level QTL 15 0.01 blood insulin amount (VT:0001560) serum insulin level (CMO:0000358) 10 57134272 102134272 Rat 724556 Pur2 Proteinuria QTL 2 5.5 urine protein amount (VT:0005160) urine protein level (CMO:0000591) 10 22427500 90627625 Rat 8662860 Vetf10 Vascular elastic tissue fragility QTL 10 artery integrity trait (VT:0010639) number of ruptures of the internal elastic lamina of the abdominal aorta and iliac arteries (CMO:0002562) 10 6154182 73453136 Rat 61387 Bp1 Blood pressure QTL 1 5.1 arterial blood pressure trait (VT:2000000) diastolic blood pressure (CMO:0000005) 10 51770177 107211142 Rat 70223 Bp57 Blood pressure QTL 57 5 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 10 1 80676123 Rat 2317043 Aia7 Adjuvant induced arthritis QTL 7 3.82 joint integrity trait (VT:0010548) left rear ankle joint diameter (CMO:0002149) 10 37565079 82565079 Rat 70224 Eae3 Experimental allergic encephalomyelitis QTL 3 4.1 nervous system integrity trait (VT:0010566) experimental autoimmune encephalomyelitis incidence/prevalence measurement (CMO:0001046) 10 26521957 61345413 Rat 2317042 Aia20 Adjuvant induced arthritis QTL 20 3.38 joint integrity trait (VT:0010548) right rear ankle joint diameter (CMO:0002150) 10 37565079 82565079 Rat 70363 Bp71 Blood pressure QTL 71 0.04 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 10 61345276 81714865 Rat 61402 Niddm3 Non-insulin dependent diabetes mellitus QTL 3 4.58 blood glucose amount (VT:0000188) blood glucose level (CMO:0000046) 10 61345413 82564856 Rat 1331791 Cm31 Cardiac mass QTL 31 3.84606 heart mass (VT:0007028) heart wet weight (CMO:0000069) 10 29299504 107211142 Rat 2313087 Bmd80 Bone mineral density QTL 80 3.2 0.0001 tibia mineral mass (VT:1000283) total volumetric bone mineral density (CMO:0001728) 10 19606483 64606483 Rat 70364 Bp72 Blood pressure QTL 72 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 10 51121100 96121100 Rat 2293698 Bss43 Bone structure and strength QTL 43 5.33 0.0001 lumbar vertebra size trait (VT:0010518) lumbar vertebra cross-sectional area (CMO:0001689) 10 59209888 104209888 Rat 631530 Tls3 T-lymphoma susceptibility QTL 3 0 0.0001 thymus integrity trait (VT:0010555) percentage of study population developing T-cell lymphomas during a period of time (CMO:0001911) 10 51774612 95600334 Rat 1354608 Cm33 Cardiac mass QTL 33 2.8 heart left ventricle mass (VT:0007031) heart left ventricle wet weight (CMO:0000071) 10 54809292 99809292 Rat 1558643 Cm44 Cardiac mass QTL 44 4.8 0.0000368 heart mass (VT:0007028) heart wet weight (CMO:0000069) 10 61345276 99703528 Rat 631535 Cm51 Cardiac mass QTL 51 3 heart mass (VT:0007028) calculated heart weight (CMO:0000073) 10 51786282 91669536 Rat 1576319 Cia29 Collagen induced arthritis QTL 29 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 10 33973921 78973921 Rat 8552805 Bw145 Body weight QTL 145 2.2 body mass (VT:0001259) change in body weight to body weight ratio (CMO:0002216) 10 41944526 78307017 Rat 631267 Cia20 Collagen induced arthritis QTL 20 3.2 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 10 23444813 104060283 Rat 2293705 Bmd25 Bone mineral density QTL 25 7.1 0.0001 femur mineral mass (VT:0010011) compact volumetric bone mineral density (CMO:0001730) 10 49444551 81709989 Rat 1331839 Eae18b Experimental allergic encephalomyelitis QTL 18b 5.8 0.03 nervous system integrity trait (VT:0010566) experimental autoimmune encephalomyelitis severity score (CMO:0001419) 10 61248303 67785171 Rat 1576308 Schws1 Schwannoma susceptibility QTL 1 0.0041 nervous system integrity trait (VT:0010566) percentage of study population developing trigeminal nerve neurilemmomas during a period of time (CMO:0002017) 10 40035094 102359817 Rat 631269 Cia22 Collagen induced arthritis QTL 22 8.9 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 10 40035094 104060283 Rat 631268 Cia21 Collagen induced arthritis QTL 21 3.1 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 10 14487011 104060283 Rat 7207811 Bmd90 Bone mineral density QTL 90 5.2 femur size trait (VT:1000369) femoral neck cross-sectional area (CMO:0001697) 10 49444551 81709989 Rat 1576311 Pia26 Pristane induced arthritis QTL 26 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 10 31224026 75632053 Rat 631270 Cia23 Collagen induced arthritis QTL 23 3.9 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 10 40035094 104060283 Rat 7411614 Foco18 Food consumption QTL 18 0.001 eating behavior trait (VT:0001431) feed conversion ratio (CMO:0001312) 10 44441699 89441699 Rat 631526 Bp76 Blood pressure QTL 76 0.0001 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 10 61345413 66743655 Rat 6893336 Cm75 Cardiac mass QTL 75 0.1 0.87 heart mass (VT:0007028) heart weight to body weight ratio (CMO:0000074) 10 61345276 99703528 Rat 631547 Bp87 Blood pressure QTL 87 4.5 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 10 47369470 92369470 Rat 61427 Cia16 Collagen induced arthritis QTL 16 3.2 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 10 6357896 96121100 Rat 2312662 Slep8 Serum leptin concentration QTL 8 0.05 blood leptin amount (VT:0005667) serum leptin level (CMO:0000780) 10 57134272 102134272 Rat 6893342 Cm78 Cardiac mass QTL 78 0.1 0.88 heart mass (VT:0007028) heart weight to body weight ratio (CMO:0000074) 10 42876766 79813922 Rat 2292441 Bp308 Blood pressure QTL 308 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 10 27606468 72606468 Rat 2313055 Bw96 Body weight QTL 96 3.6 0.0001 body mass (VT:0001259) body weight (CMO:0000012) 10 19606483 64606483 Rat 631542 Bp82 Blood pressure QTL 82 6.8 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 10 26521957 98952741 Rat 2312668 Scl65 Serum cholesterol level QTL 65 0.001 blood cholesterol amount (VT:0000180) serum total cholesterol level (CMO:0000363) 10 57134272 102134272 Rat
D10Mgh6
Rat Assembly Chr Position (strand) Source JBrowse GRCr8 10 61,843,496 - 61,843,633 (+) Marker Load Pipeline mRatBN7.2 10 61,345,276 - 61,345,413 (+) MAPPER mRatBN7.2 Rnor_6.0 10 64,648,175 - 64,648,311 NCBI Rnor6.0 Rnor_5.0 10 63,366,082 - 63,366,218 UniSTS Rnor5.0 RGSC_v3.4 10 67,677,924 - 67,678,060 UniSTS RGSC3.4 Celera 10 60,360,352 - 60,360,488 UniSTS RH 2.0 Map 10 641.2 RGD SHRSP x BN Map 10 45.5399 RGD Cytogenetic Map 10 q26 UniSTS
AU042359
Rat Assembly Chr Position (strand) Source JBrowse GRCr8 10 61,760,947 - 61,761,059 (+) Marker Load Pipeline mRatBN7.2 10 61,262,719 - 61,262,832 (+) MAPPER mRatBN7.2 Rnor_6.0 10 64,565,325 - 64,565,437 NCBI Rnor6.0 Rnor_5.0 10 63,448,935 - 63,449,047 UniSTS Rnor5.0 RGSC_v3.4 10 67,760,646 - 67,760,758 UniSTS RGSC3.4 Celera 10 60,277,708 - 60,277,820 UniSTS Cytogenetic Map 10 q26 UniSTS
BE104553
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 10 61,287,604 - 61,287,756 (+) MAPPER mRatBN7.2 Rnor_6.0 10 64,590,209 - 64,590,360 NCBI Rnor6.0 Rnor_5.0 10 63,424,012 - 63,424,163 UniSTS Rnor5.0 RGSC_v3.4 10 67,735,722 - 67,735,873 UniSTS RGSC3.4 Celera 10 60,302,593 - 60,302,744 UniSTS Cytogenetic Map 10 q26 UniSTS
Abr
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 10 61,262,558 - 61,262,725 (+) MAPPER mRatBN7.2 Rnor_6.0 10 64,565,164 - 64,565,330 NCBI Rnor6.0 Rnor_5.0 10 63,449,042 - 63,449,208 UniSTS Rnor5.0 RGSC_v3.4 10 67,760,753 - 67,760,919 UniSTS RGSC3.4 Celera 10 60,277,547 - 60,277,713 UniSTS Cytogenetic Map 10 q26 UniSTS
d10mgh6
Rat Assembly Chr Position (strand) Source JBrowse Rnor_5.0 10 63,366,082 - 63,366,219 UniSTS Rnor5.0 RGSC_v3.4 10 67,677,924 - 67,678,061 UniSTS RGSC3.4 Cytogenetic Map 10 q26 UniSTS
Click on a value in the shaded box below the category label to view a detailed expression data table for that system.
alimentary part of gastrointestinal system
9
11
49
113
91
90
59
25
59
6
218
97
93
45
60
31
Too many to show, limit is 500. Download them if you would like to view them all.
Ensembl Acc Id:
ENSRNOT00000080703 ⟹ ENSRNOP00000068811
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 10 61,262,516 - 61,376,496 (-) Ensembl Rnor_6.0 Ensembl 10 64,567,466 - 64,657,089 (-) Ensembl
Ensembl Acc Id:
ENSRNOT00000084670 ⟹ ENSRNOP00000071246
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 10 61,264,810 - 61,339,976 (-) Ensembl Rnor_6.0 Ensembl 10 64,567,268 - 64,642,292 (-) Ensembl
Ensembl Acc Id:
ENSRNOT00000098977 ⟹ ENSRNOP00000085893
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 10 61,262,516 - 61,406,014 (-) Ensembl
Ensembl Acc Id:
ENSRNOT00000105253 ⟹ ENSRNOP00000090388
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 10 61,262,516 - 61,313,583 (-) Ensembl
Ensembl Acc Id:
ENSRNOT00000109843 ⟹ ENSRNOP00000085287
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 10 61,262,516 - 61,461,505 (-) Ensembl
RefSeq Acc Id:
NM_001105814 ⟹ NP_001099284
RefSeq Status:
VALIDATED
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 10 61,760,743 - 61,903,937 (-) NCBI mRatBN7.2 10 61,262,516 - 61,405,721 (-) NCBI Rnor_6.0 10 64,565,121 - 64,657,079 (-) NCBI Rnor_5.0 10 63,250,866 - 63,449,251 (+) NCBI RGSC_v3.4 10 67,617,776 - 67,760,961 (+) RGD Celera 10 60,277,504 - 60,420,210 (-) NCBI
Sequence:
TATCTGACCAAGGAGCCTCTGCCGCACGGAGCCGCGGGCATGGAGCCGCTTAGCCACCGGGGCCTGCCGCGCCTCTCTTGGATCGACACCCTCTACAGCAACTTCAGCTACGGTGCAGAGGACTACGA CGCAGAGGGGCATGAGGAGCAGAAGGGGCCCCCCGAGGGCTCGGAGACCATGCCATACATCGACGAGTCACCCACCATGTCGCCCCAGCTCAGCGCTCGCAGCCAGGGCGGTGGGGAGAGCATCTCAC CCACCCCACCTGAGGGGTTGGCACCTGGGGTGGAGGCAGGGAAGGGCCTGGAGATGAGGAAGCTAGTTCTCTCTGGGTTTCTGGCCAGTGAAGAGATCTACATTAACCAGTTGGAAGCTCTGTTACTG CCCATGAAGCCCCTGAAGGCCACAGCCACCACCTCCCAGCCTGTGCTCACCATCCAGCAGATCGAGACCATCTTCTACAAGATCCAGGACATCTACGAGATCCACAAGGAGTTCTACGACAACCTCTG CCCCAAGGTGCAGCAGTGGGACAGCCAGGTCACCATGGGCCATCTTTTCCAGAAACTGGCCAGTCAGCTTGGCGTGTACAAAGCATTTGTGGACAACTATAAAGTCGCCCTGGAGACAGCTGAGAAGT GCAGCCAGTCCAACAACCAGTTCCAGAAGATCTCTGAGGAACTCAAAGTGAAAGGACCCAAGGACTCTAAGGACAGCCACACATCAGTCACCATGGAAGCTCTGCTGTATAAGCCTATTGACCGAGTC ACTCGGAGTACCCTGGTCCTGCACGATCTGTTGAAGCACACACCTGTGGACCACCCCGACTACCCACTGCTTCAGGATGCCCTTCGAATCTCCCAGAATTTTCTATCTAGCATTAATGAGGATATTGA TCCTCGCCGGACTGCAGTCACAACCCCCAAGGGGGAGACTCGGCAGCTGGTGAAGGACGGCTTCCTGGTGGAAATGTCTGAGAGCTCCCGGAAGCTGCGGCACGTCTTTCTCTTCACAGATGTTCTAC TGTGTGCCAAGCTAAAGAAGACCTCTGCAGGAAAACATCAGCAGTATGACTGTAAGTGGTACATCCCCCTGGCTGACTTAGTGTTCCCATCCCCTGAGGAGTCCGAGGCCAGTCCCCAGGTACACCCC TTCCCAGACCACGAGCTAGAGGACATGAAAGTGAAGATCTCTGCCCTCAAGAGTGAGATCCAGAAGGAGAAAGCCAACAAAGGACAGAGCCGAGCCATTGAGCGCCTCAAAAAGAAGATGTTTGAGAA TGAGTTCTTACTGCTGCTCAATTCCCCAACGATCCCATTCCGGATACACAATCGGAATGGAAAGAGTTACCTGTTTCTTCTGTCTTCTGACTATGAGAGGTCGGAGTGGAGAGAAGCGATTCAGAAAC TACAGAAGAAGGATCTCCAGGCCTTTGTCCTGAGCTCTGTGGAGCTCCAGGTGCTCACGGGATCCTGTTTCAAGCTTAGGACTGTGCACAACATTCCTGTCACCAGCAATAAAGATGACGATGAGTCT CCAGGACTGTACGGCTTCCTTCATGTCATCGTCCACTCTGCCAAGGGCTTTAAACAATCAGCCAATCTTTACTGTACTCTGGAGGTGGATTCCTTTGGCTATTTTGTCAGCAAAGCCAAAACCAGGGT GTTTCGGGACACGACAGAGCCCAAGTGGGATGAGGAGTTTGAGATTGAGCTGGAGGGCTCCCAGTCCCTGAGGATCCTGTGCTATGAGAAATGCTATGACAAGACCAAGGTCAACAAGGACAACAATG AGATTGTGGACAAGATCATGGGCAAGGGGCAGATCCAGCTGGATCCACAGACAGTAGAAAGCAAGAACTGGCATACGGATGTGATTGAAATGAATGGGATCAAAGTGGAATTCTCCATGAAATTTACC AGCCGTGACATGAGCCTGAAGAGGACTCCATCCAAAAAGCAGACAGGTGTCTTCGGAGTGAAGATCAGTGTGGTGACCAAGCGGGAGCGCTCCAAGGTGCCCTACATAGTCCGGCAGTGCATAGAAGA GGTGGAGAAGAGGGGCATCGAGGAGGTTGGCATCTACAGGATATCAGGGGTGGCCACGGACATCCAGGCCCTGAAGGCTGTCTTTGATGCCAATAACAAGGATATCCTACTGATGCTGAGTGACATGG ACATCAACGCTATTGCTGGTACCCTCAAGCTCTACTTTCGGGAGCTGCCTGAGCCCCTCCTTACAGACCGACTCTACCCAGCCTTCATGGAGGGCATTGCCCTGTCAGATCCTGCTGCCAAGGAGAAC TGCATGATGCACCTACTCCGTTCCCTGCCCGACCCCAACCTCATCACCTTCCTTTTCCTGCTGGAACACTTGAAAAGGGTTGCCGAGAAGGAGCCCATCAACAAGATGTCACTTCACAACCTTGCCAC AGTGTTTGGCCCCACGTTACTGAGACCCTCAGAAGTGGAGAGCAAAGCACATCTCACATCAGCTGCAGACATCTGGTCCCATGATGTCATGGCCCAGGTCCAGGTCCTACTCTACTACCTGCAGCATC CCCCCATTTCCTTCGCAGAACTGAAGCGGAACACACTGTACTTCTCCACAGACGTGTAGCCTGGGGTGGGCAGCTGTGGGGGTGGCCAGCGCCAGCCCTCCAGCCGGGGCCCAACATAGACTTGAAAG ACTGCAACAGAAACTCCCCAGCCTAGCACTCCAGAGTCCGGGGGAAGCCACCTTCCAAGAACTGGAACACGTGCATCTTTTGTGCCACCTTGTACAAAGCCAGCTGACCAGCCCCCGCCTCCTCACCA CACCCCAGCTCCTTCCCTCCGTACCTGAGTGTGTCTGATGCTCCGTGCTGTCCAGGAATTGTTTTATGTATATTTGTCATTGCAGAAAAGGTAGTGGCCGAGCTGGTGTGGGCACAGACAGCTTGCTT TGTTCTTTCATTTCTCCCAACTCTTCTTTCTGCCTGAGTCCAGTCCAAGGACTTTTACTTTGCGCTGTGTAACTGCTGCCAGCTTCTCCTCTCCTGGCCCTGCTCCCAGATTGCAGCCTCCCTGCAGT GTCTGCCCTCTCCACCTCCCAGCCTGCTGCATGCATGTGCAGCATGGGCTTTTGCTCCATCACTGCAAAGTTCTGCAGGGGCCCTGGGCAGTGCTGGCCTGTCTGATGTGCTGCCCCTGGCCTCCTTG CTCTCCACATGTGGAAGCACATCTGCTTTCCTTGCTGTCTGTGCAAATGTTGAACAAGGAGACAGACACACACTAATCCTCAGCACAGAGCTGGAGAGCTCATTTCTGGAATGTTCTATTTGAGAATT GCCATTTCTGGGGTTTGTCTGTTCTATCTCCTGCCTACCAGTACGGCATCTTCAGCTGTTTCTTCTATGGCTGAATTTTCTGTTCCTTTTCCCTGGTGTTCTATTTTCTTTGAGTGTAATGACCTACA AGTGTCCTGCCATCATAGAGGTCAGGATTGCACCTGAAGGGTATGGTGGGCACCCAGGCTGTGAAGGAACAAGATGGGTGGAGCAGCCAGCAGTGGCAAGTCAAGGGAAGCCAGTCTTCACACTAAGG ACCGGCAGAGGCTATCCTAGTGGAGTACAGCCTCCTGGAGGGCAGCTTCTGTGGCTGAATCAGGTGTCCAGGTGAAAACAGGAACCTGGAACCACACATACCTCGTGGTATTTTTGCCTTAGATTTTA CACTCTCAACAGCCAAGCACTGCCACGGGGCAGCCACATTGCCATGCGTGCTCCAGAGCCTAGGAACAGCAGATAGAACCCAGTGGAATGCTTCTACCCTGGCTTCTGAATCCAGGCCTGTGGGTAAT CCCAAGCATACAGAAGTTGTGGAGTAGGAAGCCTCTCTTGTCAATGAGTTCTGCTGGGGCTGTAGGGCATCAGGTCAGCAGGTGTCATTCCCAGCTGTGACCCATTGCTTGGTACTAAAAAGGAGTTT TACTCCCAAAGTAAGGTTTCCAGCCTGAGCAGGAGCTACCAGCCTGTGGCAATTAGCACGGAAAGAAAGGTGCTCCTGTCATAGGGGCTTGAGCTACCATACAGCTTCCTGTTTCTTCTATATGGCAG AGTTCTTTCATTCTTGGCCCTCAGGATTGGGGAGACCAGCTCTCATTGTGTGTGCTCAGGGCTAAGTCTAAACAAGGGTTTGCTGGCCCCCAAGCTGTTGTTTGCTAGGTGAGGTTAGGTAGGGCTCT CCTGGTCCTGTTCATACCTATTGCCTTTGACAGAACGGTACAGTTTGTTCATGCAGGAGGAAGGAATGCCAACTTCCCAGCTGCCTATTAGCAGTTTAACAAGGAGCCTTGCTGTCTCAAACAGGTGA AAGAAAATGCTGTGTGTAAAGATCACATCTGCCACTATCTTGGCGCTCAGGTGTGGGTATGTGGTGTTCTTGCTTCAAAGGATTGATGGTAACAAATTATCAAAGCTTGACTGGAGCTGGCTGCAGCT CAAAACAGTGCCCCCTGCCTCTGTAGAGCAAAGATGTGGGCCCTGCATCAGCTGCTACAGCCACAGCTTATTTAGGCAGTGACAGCAGGGAGGCCAGAGGAGCTGAGGACTGTTAAACGTTCCCATTA TTTATAAATTCCACCCAAAGTGGACAGTCAGGTGCCAGATCTGAAGTGCACCAAGGAAGTACCTGGTGGTTCTCCGGAGACGGGCCATGCAGCCCAGAACCCCCGCACCGTCAGCAGGGCACCAGGAG ACAGGGTCCAGGAATCCGGGTATGCCTGTACTTGCTTGTGCAACGACTGAGGGCTGCCAGCTTTTGCTGATGAGGTAGGATGGGACTCCCAATAAGTTGGTATGGATATATTTTTTTTTTGTCTCTGT TCTGTTTAAACTTATGTAGATTATTATAAATTGATGTAAACCACGTGAGAGGGAAATGTTAATAAAAAAATGCAAAGCCTCAACATTTGCACAAAACTCA
hide sequence
RefSeq Acc Id:
XM_039085523 ⟹ XP_038941451
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 10 61,760,743 - 61,959,526 (-) NCBI mRatBN7.2 10 61,262,516 - 61,461,331 (-) NCBI
RefSeq Acc Id:
XM_039085524 ⟹ XP_038941452
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 10 61,760,743 - 61,958,441 (-) NCBI mRatBN7.2 10 61,264,726 - 61,460,247 (-) NCBI
RefSeq Acc Id:
XM_039085527 ⟹ XP_038941455
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 10 61,760,743 - 61,910,652 (-) NCBI mRatBN7.2 10 61,264,726 - 61,412,400 (-) NCBI
RefSeq Acc Id:
XM_039085528 ⟹ XP_038941456
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 10 61,760,743 - 61,957,513 (-) NCBI mRatBN7.2 10 61,264,726 - 61,459,311 (-) NCBI
RefSeq Acc Id:
XM_039085529 ⟹ XP_038941457
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 10 61,760,743 - 61,838,920 (-) NCBI mRatBN7.2 10 61,264,861 - 61,339,626 (-) NCBI
RefSeq Acc Id:
XM_039085530 ⟹ XP_038941458
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 10 61,760,743 - 61,910,627 (-) NCBI mRatBN7.2 10 61,264,861 - 61,412,343 (-) NCBI
RefSeq Acc Id:
XM_039085531 ⟹ XP_038941459
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 10 61,760,743 - 61,957,511 (-) NCBI mRatBN7.2 10 61,264,861 - 61,459,311 (-) NCBI
RefSeq Acc Id:
XM_039085532 ⟹ XP_038941460
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 10 61,760,743 - 61,812,110 (-) NCBI mRatBN7.2 10 61,264,861 - 61,313,879 (-) NCBI
RefSeq Acc Id:
XM_039085533 ⟹ XP_038941461
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 10 61,760,743 - 61,789,509 (-) NCBI mRatBN7.2 10 61,264,861 - 61,283,114 (-) NCBI
RefSeq Acc Id:
NP_001099284 ⟸ NM_001105814
- UniProtKB:
A0A0G2JTR4 (UniProtKB/Swiss-Prot), A6HGV7 (UniProtKB/TrEMBL), A0A4X0W8E9 (UniProtKB/TrEMBL)
- Sequence:
MEPLSHRGLPRLSWIDTLYSNFSYGAEDYDAEGHEEQKGPPEGSETMPYIDESPTMSPQLSARSQGGGESISPTPPEGLAPGVEAGKGLEMRKLVLSGFLASEEIYINQLEALLLPMKPLKATATTSQ PVLTIQQIETIFYKIQDIYEIHKEFYDNLCPKVQQWDSQVTMGHLFQKLASQLGVYKAFVDNYKVALETAEKCSQSNNQFQKISEELKVKGPKDSKDSHTSVTMEALLYKPIDRVTRSTLVLHDLLKH TPVDHPDYPLLQDALRISQNFLSSINEDIDPRRTAVTTPKGETRQLVKDGFLVEMSESSRKLRHVFLFTDVLLCAKLKKTSAGKHQQYDCKWYIPLADLVFPSPEESEASPQVHPFPDHELEDMKVKI SALKSEIQKEKANKGQSRAIERLKKKMFENEFLLLLNSPTIPFRIHNRNGKSYLFLLSSDYERSEWREAIQKLQKKDLQAFVLSSVELQVLTGSCFKLRTVHNIPVTSNKDDDESPGLYGFLHVIVHS AKGFKQSANLYCTLEVDSFGYFVSKAKTRVFRDTTEPKWDEEFEIELEGSQSLRILCYEKCYDKTKVNKDNNEIVDKIMGKGQIQLDPQTVESKNWHTDVIEMNGIKVEFSMKFTSRDMSLKRTPSKK QTGVFGVKISVVTKRERSKVPYIVRQCIEEVEKRGIEEVGIYRISGVATDIQALKAVFDANNKDILLMLSDMDINAIAGTLKLYFRELPEPLLTDRLYPAFMEGIALSDPAAKENCMMHLLRSLPDPN LITFLFLLEHLKRVAEKEPINKMSLHNLATVFGPTLLRPSEVESKAHLTSAADIWSHDVMAQVQVLLYYLQHPPISFAELKRNTLYFSTDV
hide sequence
Ensembl Acc Id:
ENSRNOP00000068811 ⟸ ENSRNOT00000080703
Ensembl Acc Id:
ENSRNOP00000071246 ⟸ ENSRNOT00000084670
RefSeq Acc Id:
XP_038941451 ⟸ XM_039085523
- Peptide Label:
isoform X1
- UniProtKB:
A0A8I6A3Q6 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_038941452 ⟸ XM_039085524
- Peptide Label:
isoform X2
- UniProtKB:
A0A4X0W8E9 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_038941456 ⟸ XM_039085528
- Peptide Label:
isoform X3
- UniProtKB:
A0A8I6A171 (UniProtKB/TrEMBL), A0A4X0W8E9 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_038941455 ⟸ XM_039085527
- Peptide Label:
isoform X3
- UniProtKB:
A0A8I6A171 (UniProtKB/TrEMBL), A0A4X0W8E9 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_038941459 ⟸ XM_039085531
- Peptide Label:
isoform X5
- UniProtKB:
A0A4X0W8E9 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_038941458 ⟸ XM_039085530
- Peptide Label:
isoform X5
- UniProtKB:
A0A4X0W8E9 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_038941457 ⟸ XM_039085529
- Peptide Label:
isoform X4
- UniProtKB:
A0A0G2JZZ7 (UniProtKB/TrEMBL), A0A4X0W8E9 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_038941460 ⟸ XM_039085532
- Peptide Label:
isoform X6
- UniProtKB:
A0A8I6GI56 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_038941461 ⟸ XM_039085533
- Peptide Label:
isoform X7
Ensembl Acc Id:
ENSRNOP00000085893 ⟸ ENSRNOT00000098977
Ensembl Acc Id:
ENSRNOP00000090388 ⟸ ENSRNOT00000105253
Ensembl Acc Id:
ENSRNOP00000085287 ⟸ ENSRNOT00000109843
Date
Current Symbol
Current Name
Previous Symbol
Previous Name
Description
Reference
Status
2021-03-09
Abr
ABR activator of RhoGEF and GTPase
LOC103693389
breakpoint cluster region protein-like
Data merged from RGD:9174117
737654
PROVISIONAL
2019-03-25
Abr
ABR activator of RhoGEF and GTPase
Abr
ABR, RhoGEF and GTPase activating protein
Nomenclature updated to reflect human and mouse nomenclature
1299863
APPROVED
2018-02-23
Abr
ABR, RhoGEF and GTPase activating protein
Abr
active BCR-related
Nomenclature updated to reflect human and mouse nomenclature
1299863
APPROVED
2015-07-29
LOC103693389
breakpoint cluster region protein-like
LOC687983
similar to Breakpoint cluster region protein
Data merged from RGD:1594868
737654
PROVISIONAL
2014-08-25
LOC103693389
breakpoint cluster region protein-like
Symbol and Name status set to provisional
70820
PROVISIONAL
2012-07-13
Abr
active BCR-related
Abr
active BCR-related gene
Nomenclature updated to reflect human and mouse nomenclature
1299863
APPROVED
2008-04-30
Abr
active BCR-related gene
Abr_predicted
active BCR-related gene (predicted)
'predicted' is removed
2292626
APPROVED
2006-11-20
LOC687983
similar to Breakpoint cluster region protein
Symbol and Name status set to provisional
70820
PROVISIONAL
2005-01-12
Abr_predicted
active BCR-related gene (predicted)
Symbol and Name status set to approved
70820
APPROVED